ribavirin has been researched along with Deafness Unilateral in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cornberg, M; Hadem, J; Hauptmann, C; Manns, MP; Süttmann, U; Wedemeyer, H | 1 |
Jain, S; Midha, V; Sood, A | 1 |
Adinolfi, LE; Barillari, M; Costa, G; Marrone, A; Zampino, R | 1 |
3 other study(ies) available for ribavirin and Deafness Unilateral
Article | Year |
---|---|
Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy.
Topics: Adult; Antiviral Agents; Bacterial Proteins; Cefotaxime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Hearing Loss, Unilateral; Hepatitis C, Chronic; Humans; Infusions, Intravenous; Interferon Type I; Interferon-alpha; Male; Meningitis, Pneumococcal; Opportunistic Infections; Penicillin G; Pneumococcal Vaccines; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Splenectomy | 2008 |
Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.
Topics: Adult; Antiviral Agents; Audiometry, Pure-Tone; Drug Therapy, Combination; Earache; Hearing Loss, Unilateral; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Reversible sudden hearing loss in a chronic hepatitis C patient who achieved a sustained response to antiviral re-treatment.
Topics: Alanine Transaminase; Anemia; Antiviral Agents; Biomarkers; Drug Monitoring; Drug Substitution; Drug Therapy, Combination; Hearing Loss, Sudden; Hearing Loss, Unilateral; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2012 |